The role of PBSCT in treatment of AL amyloidosis is far from settled [4] (multiple letters)

Blood

Volumn 104, Issue 9, 2004, Pages 2991-2994

  Goodman, Hugh J B ^a   Hawkins, Philip N ^a   Dispenzieri, Angela ^b   Gertz, Morie A ^b   Kyle, Robert A ^b   Mehta, Jayesh ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MAYO CLINIC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' IODOESORUBICIN; ALPHA TOCOPHEROL; COLCHICINE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

AMYLOIDOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 7244219938     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2085     Document Type: Letter

References (0)